ADAR1 Capital Management »

Futuretech Ii Acquisition shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Futuretech Ii Acquisition (FTIIW) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Futuretech Ii Acquisition

Tip: Access up to 7 years of quarterly data

All positions including Futuretech Ii Acquisition held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Futuretech Ii Acquisition by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.2k 30k 0.04
2023-12-31 $447 30k 0.01

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Futuretech Ii Acquisition

Clear Street Derivatives
Highbridge Capital Management
Polar Securities
Saba Capital Management
Atw Spac Management
Calamos Advisors
Hudson Bay Capital Management
MMCAP International Inc. SPC
Shaolin Capital Management
Verition Fund Management
D. E. Shaw & Co
Wolverine Asset Management
Periscope Capital
Whitebox Advisors
Context Capital Management

View all funds holding Futuretech Ii Acquisition